Greenridge Global Comments on EUDA Health FY2025 Earnings

EUDA Health Holdings Limited (NASDAQ:EUDA) – Analysts at Greenridge Global decreased their FY2025 earnings estimates for shares of EUDA Health in a report issued on Monday, March 9th. Greenridge Global analyst W. Gregozeski now expects that the company will post earnings per share of ($0.01) for the year, down from their previous estimate of $0.02. Greenridge Global currently has a “Buy” rating and a $2.75 target price on the stock. The consensus estimate for EUDA Health’s current full-year earnings is ($0.33) per share.

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of EUDA Health in a report on Friday, January 9th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, EUDA Health presently has a consensus rating of “Hold” and a consensus price target of $2.75.

EUDA Health Stock Up 4.2%

Shares of EUDA opened at $0.51 on Tuesday. The firm has a market capitalization of $19.31 million, a price-to-earnings ratio of -4.26 and a beta of -0.11. EUDA Health has a 12-month low of $0.46 and a 12-month high of $4.30. The stock’s 50-day moving average price is $1.37 and its 200 day moving average price is $2.01.

Institutional Investors Weigh In On EUDA Health

An institutional investor recently bought a new position in EUDA Health stock. Jane Street Group LLC bought a new position in shares of EUDA Health Holdings Limited (NASDAQ:EUDA) in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned approximately 0.07% of EUDA Health at the end of the most recent quarter. Hedge funds and other institutional investors own 4.35% of the company’s stock.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.